With Covered California enrollment ongoing, consumers wonder if they qualify for subsidies.

One breast cancer drug showed particular ability to reach tumors in the brain, which are notoriously tough to treat.

Supreme Court seems supportive of a $12-billion claim by insurers who say they covered high-risk patients, then were subject to a "bait-and-switch."

Better than pricing drugs according to "value" would be to have the federal government force pharmaceutical companies not to overcharge.

Experts at Stanford and the IRS found that the Obamacare mandate got people to buy insurance, and the insurance reduced death rates

The university hired a firm that mailed out a "confidential survey" designed to prompt people to purchase health-related books costing about $100.

A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia. The benefit was clear.